136 related articles for article (PubMed ID: 12916936)
1. A study of the antiresorptive activity of salmon calcitonin microspheres using cultured osteoclastic cells.
Dani BA; Raiche AT; Puleo DA; DeLuca PP
AAPS PharmSciTech; 2002; 3(3):E21. PubMed ID: 12916936
[TBL] [Abstract][Full Text] [Related]
2. Preparation, characterization, and in vivo evaluation of salmon calcitonin microspheres.
Dani BA; DeLuca PP
AAPS PharmSciTech; 2001 Oct; 2(4):22. PubMed ID: 14727859
[TBL] [Abstract][Full Text] [Related]
3. Adsorption of salmon calcitonin to PLGA microspheres.
Calis S; Jeyanthi R; Tsai T; Mehta RC; DeLuca PP
Pharm Res; 1995 Jul; 12(7):1072-6. PubMed ID: 7494805
[TBL] [Abstract][Full Text] [Related]
4. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
Liu BY; Wang JT; Leu JS; Chiang CP; Hsieh CC; Kwan HW
J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
[TBL] [Abstract][Full Text] [Related]
5. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
6. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.
Glowka E; Sapin-Minet A; Leroy P; Lulek J; Maincent P
J Microencapsul; 2010; 27(1):25-36. PubMed ID: 19229671
[TBL] [Abstract][Full Text] [Related]
8. Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.
Duvvuri S; Janoria KG; Pal D; Mitra AK
J Ocul Pharmacol Ther; 2007 Jun; 23(3):264-74. PubMed ID: 17593010
[TBL] [Abstract][Full Text] [Related]
9. Long-term culture of disaggregated rat osteoclasts: inhibition of bone resorption and reduction of osteoclast-like cell number by calcitonin and PTHrP[107-139].
Fenton AJ; Martin TJ; Nicholson GC
J Cell Physiol; 1993 Apr; 155(1):1-7. PubMed ID: 8468357
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic evaluation of the calcitonin analogue SB 205614 in models of osteoclastic bone resorption in vitro and in vivo: comparison with salmon calcitonin and elcatonin.
McSheehy PM; Farina C; Airaghi R; Allievi E; Banfi S; Bertolini D; Ferni G; Frattola D; Oneta S; Pinza M
Bone; 1995 Apr; 16(4):435-44. PubMed ID: 7605704
[TBL] [Abstract][Full Text] [Related]
11. The characterization of paclitaxel-loaded microspheres manufactured from blends of poly(lactic-co-glycolic acid) (PLGA) and low molecular weight diblock copolymers.
Jackson JK; Hung T; Letchford K; Burt HM
Int J Pharm; 2007 Sep; 342(1-2):6-17. PubMed ID: 17555895
[TBL] [Abstract][Full Text] [Related]
12. Design and Characterizations of Inhalable Poly(lactic-
Sato H; Tabata A; Moritani T; Morinaga T; Mizumoto T; Seto Y; Onoue S
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183032
[TBL] [Abstract][Full Text] [Related]
13. Characterization of ciclosporin A loaded poly (D,L lactide-co-glycolide) microspheres using modulated temperature differential scanning calorimetry.
Passerini N; Craig DQ
J Pharm Pharmacol; 2002 Jul; 54(7):913-9. PubMed ID: 12162709
[TBL] [Abstract][Full Text] [Related]
14. Vasoactive intestinal peptide regulates osteoclast activity via specific binding sites on both osteoclasts and osteoblasts.
Lundberg P; Lie A; Bjurholm A; Lehenkari PP; Horton MA; Lerner UH; Ransjö M
Bone; 2000 Dec; 27(6):803-10. PubMed ID: 11113391
[TBL] [Abstract][Full Text] [Related]
15. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity.
Hazekawa M; Sakai Y; Yoshida M; Haraguchi T; Morisaki T; Uchida T
J Pharm Pharmacol; 2011 Mar; 63(3):362-8. PubMed ID: 21749383
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Samura A; Wada S; Suda S; Iitaka M; Katayama S
Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
[TBL] [Abstract][Full Text] [Related]
17. Biodegradable nanoparticles containing protein-fatty acid complexes for oral delivery of salmon calcitonin.
Sang Yoo H; Gwan Park T
J Pharm Sci; 2004 Feb; 93(2):488-95. PubMed ID: 14705204
[TBL] [Abstract][Full Text] [Related]
18. Peptide acylation by poly(alpha-hydroxy esters).
Lucke A; Kiermaier J; Göpferich A
Pharm Res; 2002 Feb; 19(2):175-81. PubMed ID: 11883645
[TBL] [Abstract][Full Text] [Related]
19. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of salmon calcitonin on bone resorption: morphological study of the tibial growth plate in rats.
Pazzaglia UE; Zatti G; Di Nucci A; Coci A
Calcif Tissue Int; 1993 Feb; 52(2):125-9. PubMed ID: 8443688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
